Kangmei Pharmaceutical Co Ltd Cash Flow Quality Index
Kangmei Pharmaceutical Co Ltd cash flow quality index. Kangmei Pharmaceutical Co Ltd (600518) has a Cash Flow Quality Index of 2.30x as of June 2025. Operating cash flow of CN¥19.27 Million exceeds net income of CN¥8.40 Million, indicating high earnings quality where cash backs reported profits. See 600518 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Kangmei Pharmaceutical Co Ltd (1999–2024)
Cash flow quality index of Kangmei Pharmaceutical Co Ltd from 1999 to 2024. Historical Cash Flow Quality Index for Kangmei Pharmaceutical Co Ltd across 23 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of Kangmei Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.
Kangmei Pharmaceutical Co Ltd Cash Flow Quality Index by Year (1999–2024)
Kangmei Pharmaceutical Co Ltd cash flow quality index by year from 1999 to 2024. Year-by-year earnings quality comparison for Kangmei Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Kangmei Pharmaceutical Co Ltd cash conversion from operations.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -49.88x | CN¥-427.63 Million | CN¥8.57 Million | ▼ -1510.4% |
| 2023 | -3.10x | CN¥-317.52 Million | CN¥102.52 Million | ▼ -11551.2% |
| 2021 | 0.03x | CN¥214.21 Million | CN¥7.92 Billion | ▼ -96.7% |
| 2018 | 0.83x | CN¥305.62 Million | CN¥370.04 Million | ▲ +169.9% |
| 2017 | -1.18x | CN¥-4.84 Billion | CN¥4.09 Billion | ▼ -346.0% |
| 2016 | 0.48x | CN¥1.60 Billion | CN¥3.34 Billion | ▲ +160.3% |
| 2015 | 0.18x | CN¥508.86 Million | CN¥2.76 Billion | ▼ -62.7% |
| 2014 | 0.50x | CN¥1.13 Billion | CN¥2.29 Billion | ▼ -44.4% |
| 2013 | 0.89x | CN¥1.67 Billion | CN¥1.88 Billion | ▲ +27.3% |
| 2012 | 0.70x | CN¥1.01 Billion | CN¥1.44 Billion | ▲ +22.3% |
| 2011 | 0.57x | CN¥574.96 Million | CN¥1.01 Billion | ▼ -38.8% |
| 2010 | 0.94x | CN¥669.19 Million | CN¥715.52 Million | ▲ +292.6% |
| 2009 | 0.24x | CN¥119.47 Million | CN¥501.51 Million | ▲ +2227.4% |
| 2008 | 0.01x | CN¥3.02 Million | CN¥294.57 Million | ▼ -99.1% |
| 2007 | 1.11x | CN¥162.55 Million | CN¥146.11 Million | ▲ +62.7% |
| 2006 | 0.68x | CN¥68.32 Million | CN¥99.89 Million | ▼ -62.7% |
| 2005 | 1.83x | CN¥133.13 Million | CN¥72.65 Million | ▲ +66.2% |
| 2004 | 1.10x | CN¥78.52 Million | CN¥71.21 Million | ▼ -27.6% |
| 2003 | 1.52x | CN¥78.02 Million | CN¥51.20 Million | ▲ +24.9% |
| 2002 | 1.22x | CN¥53.47 Million | CN¥43.83 Million | ▲ +126.7% |
| 2001 | 0.54x | CN¥15.69 Million | CN¥29.16 Million | ▲ +32.6% |
| 2000 | 0.41x | CN¥9.96 Million | CN¥24.55 Million | ▼ -66.0% |
| 1999 | 1.19x | CN¥30.25 Million | CN¥25.35 Million | — |